Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01976169
Title Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Texas Southwestern Medical Center|Pfizer|University of Pennsylvania
Indications

Her2-receptor positive breast cancer

Therapies

Ado-trastuzumab emtansine + Palbociclib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UT Southwestern Medical Center Dallas Texas 75390 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field